$USPH
U S PHYSICAL THERAPY INC /NV

2023 Q4 Form 10-Q Financial Statement

#000114036123052081 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $154.8M $150.0M
YoY Change 9.65% 7.45%
Cost Of Revenue $124.3M $122.1M
YoY Change 9.65% 8.23%
Gross Profit $30.52M $27.93M
YoY Change 9.65% 4.27%
Gross Profit Margin 19.71% 18.62%
Selling, General & Admin $13.90M $12.05M
YoY Change 16.57% 1.34%
% of Gross Profit 45.55% 43.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.113M $3.960M
YoY Change 8.44% 8.43%
% of Gross Profit 13.48% 14.18%
Operating Expenses $13.90M $12.05M
YoY Change 16.57% 1.34%
Operating Profit $16.61M $15.88M
YoY Change 4.46% 6.62%
Interest Expense -$193.0K -$100.0K
YoY Change -90.24% -93.92%
% of Operating Profit -1.16% -0.63%
Other Income/Expense, Net $1.179M -$102.0K
YoY Change -560.55% -103.66%
Pretax Income $106.0K $15.78M
YoY Change -97.68% -1.6%
Income Tax $1.399M $3.557M
% Of Pretax Income 1319.81% 22.54%
Net Earnings -$5.729M $9.254M
YoY Change 3851.03% -3.17%
Net Earnings / Revenue -3.7% 6.17%
Basic Earnings Per Share $0.51
Diluted Earnings Per Share -$0.38 $0.51
COMMON SHARES
Basic Shares Outstanding 14.99M 14.99M
Diluted Shares Outstanding 14.99M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $152.8M $147.7M
YoY Change 383.72% 289.57%
Cash & Equivalents $152.8M $147.7M
Short-Term Investments
Other Short-Term Assets $10.83M $9.387M
YoY Change -2.14% 54.26%
Inventory
Prepaid Expenses
Receivables $51.87M $52.96M
Other Receivables $0.00 $0.00
Total Short-Term Assets $233.4M $228.5M
YoY Change 109.75% 102.4%
LONG-TERM ASSETS
Property, Plant & Equipment $26.10M $26.07M
YoY Change 5.47% -79.31%
Goodwill $509.6M $522.9M
YoY Change 3.13% 16.32%
Intangibles $109.7M $112.1M
YoY Change 0.85% 19.65%
Long-Term Investments $12.26M $12.30M
YoY Change 1.03% 2.69%
Other Assets $2.821M $5.679M
YoY Change -32.01% 1.07%
Total Long-Term Assets $763.9M $781.7M
YoY Change 2.27% 13.81%
TOTAL ASSETS
Total Short-Term Assets $233.4M $228.5M
Total Long-Term Assets $763.9M $781.7M
Total Assets $997.2M $1.010B
YoY Change 16.21% 26.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.898M $4.500M
YoY Change -40.07% -41.36%
Accrued Expenses $55.34M $35.85M
YoY Change 47.93% -45.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.691M $7.555M
YoY Change -2.19% 0.87%
Total Short-Term Liabilities $102.2M $82.36M
YoY Change 19.53% 1.07%
LONG-TERM LIABILITIES
Long-Term Debt $139.0M $141.5M
YoY Change -20.95% -3.54%
Other Long-Term Liabilities $2.356M $14.76M
YoY Change -81.92% -81.77%
Total Long-Term Liabilities $141.3M $156.3M
YoY Change -25.16% -31.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $102.2M $82.36M
Total Long-Term Liabilities $141.3M $156.3M
Total Liabilities $345.0M $342.0M
YoY Change -7.65% -29.13%
SHAREHOLDERS EQUITY
Retained Earnings $223.8M $238.6M
YoY Change -3.94% 1.22%
Common Stock $172.0K $172.0K
YoY Change 13.16% 13.16%
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M $31.63M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $476.2M $492.0M
YoY Change
Total Liabilities & Shareholders Equity $997.2M $1.010B
YoY Change 16.21% 26.32%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$5.729M $9.254M
YoY Change 3851.03% -3.17%
Depreciation, Depletion And Amortization $4.113M $3.960M
YoY Change 8.44% 8.43%
Cash From Operating Activities $26.83M $16.36M
YoY Change 55.12% 19.18%
INVESTING ACTIVITIES
Capital Expenditures $2.220M $2.550M
YoY Change 131.73% -193.72%
Acquisitions
YoY Change
Other Investing Activities -$6.194M -$14.39M
YoY Change -85.4% 23.87%
Cash From Investing Activities -$8.414M -$16.94M
YoY Change -80.61% 18.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.28M -12.48M
YoY Change -167.17% 24.22%
NET CHANGE
Cash From Operating Activities 26.83M 16.36M
Cash From Investing Activities -8.414M -16.94M
Cash From Financing Activities -13.28M -12.48M
Net Change In Cash 5.140M -13.06M
YoY Change -181.33% 22.54%
FREE CASH FLOW
Cash From Operating Activities $26.83M $16.36M
Capital Expenditures $2.220M $2.550M
Free Cash Flow $24.61M $13.81M
YoY Change 50.63% -16.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Entity File Number
EntityFileNumber
1-11151
dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 300
dei Entity Address City Or Town
EntityAddressCityOrTown
HOUSTON
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
dei Local Phone Number
LocalPhoneNumber
297-7000
dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
dei Trading Symbol
TradingSymbol
USPH
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14987042
CY2023Q3 us-gaap Revenues
Revenues
150007000
CY2022Q3 us-gaap Revenues
Revenues
139602000
us-gaap Revenues
Revenues
450001000
us-gaap Revenues
Revenues
411962000
CY2023Q3 us-gaap Gross Profit
GrossProfit
27929000
CY2022Q3 us-gaap Gross Profit
GrossProfit
26784000
us-gaap Gross Profit
GrossProfit
90993000
us-gaap Gross Profit
GrossProfit
84193000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
dei Entity Central Index Key
EntityCentralIndexKey
0000885978
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0364866
dei Entity Address Address Line1
EntityAddressAddressLine1
1300 WEST SAM HOUSTON PARKWAY SOUTH
dei City Area Code
CityAreaCode
713
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q3 usph Accounts Payable Due To Seller Of Acquired Business
AccountsPayableDueToSellerOfAcquiredBusiness
0
CY2022Q4 usph Accounts Payable Due To Seller Of Acquired Business
AccountsPayableDueToSellerOfAcquiredBusiness
3204000
CY2023Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
31000000
us-gaap Payments For Proceeds From Limited Partnership
PaymentsForProceedsFromLimitedPartnership
-7000
us-gaap Payments For Proceeds From Limited Partnership
PaymentsForProceedsFromLimitedPartnership
-740000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17683000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15990000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
24000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
61000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
150000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163646000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
55000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
175000000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
50000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
12000
CY2022Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
0
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3064000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1580000
CY2023Q3 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
200000
CY2022Q3 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
576000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
489998000
CY2023Q3 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-2242000
CY2023Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
249000
CY2023Q3 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
30000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1859000
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6445000
CY2023Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
941000
CY2023Q3 usph Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity
DeferredTaxesRelatedToRedeemableNonControllingInterestTemporaryEquity
323000
CY2023Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
48000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-9000
CY2023Q3 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
992000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9254000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
950000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
493508000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317053000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-4988000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
288000
us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
30000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5451000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17683000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3035000
usph Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity
DeferredTaxesRelatedToRedeemableNonControllingInterestTemporaryEquity
697000
us-gaap Stockholders Equity Other
StockholdersEquityOther
50000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
163642000
usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
3314000
us-gaap Net Income Loss
NetIncomeLoss
27583000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1742000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
493508000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
308933000
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2022Q3 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-147000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1802000
CY2022Q3 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
0
CY2022Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
94000
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5331000
CY2022Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1519000
CY2022Q3 usph Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity
DeferredTaxesRelatedToRedeemableNonControllingInterestTemporaryEquity
-643000
CY2022Q3 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
1227000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
9557000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4819000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
318604000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297181000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
-144000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5462000
usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
707000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
454000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15990000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3990000
usph Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity
DeferredTaxesRelatedToRedeemableNonControllingInterestTemporaryEquity
-2129000
us-gaap Stockholders Equity Other
StockholdersEquityOther
697000
usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
3288000
us-gaap Net Income Loss
NetIncomeLoss
29551000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4424000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
318604000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
672
CY2023Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
42
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1916667
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
90
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163600000
CY2023Q2 usph Underwriting Discount
UnderwritingDiscount
8600000
CY2023Q2 usph Stock Issuance Expense
StockIssuanceExpense
200000
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35000000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
usph Number Of Regions
NumberOfRegions
6
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.27
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14987000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14987000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13001000
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023Q3 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2022Q3 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
100000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
300000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3900000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3500000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9254000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
9557000
us-gaap Net Income Loss
NetIncomeLoss
27583000
us-gaap Net Income Loss
NetIncomeLoss
29551000
CY2023Q3 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-2242000
CY2022Q3 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-196000
usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-4988000
usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-193000
CY2023Q3 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-573000
CY2022Q3 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-50000
usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-1274000
usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-49000
CY2023Q3 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
7585000
CY2022Q3 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
9411000
usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
23869000
usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
29407000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13001000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13918000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13918000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12979000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12979000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
150007000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139602000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
450001000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
411962000
CY2022Q4 us-gaap Goodwill
Goodwill
494101000
CY2021Q4 us-gaap Goodwill
Goodwill
434679000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
25932000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
72674000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
2874000
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-4140000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9112000
CY2023Q3 us-gaap Goodwill
Goodwill
522907000
CY2022Q4 us-gaap Goodwill
Goodwill
494101000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9100000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
112112000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
108755000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1817000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1533000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5422000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4811000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17650000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22912000
CY2023Q3 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
8183000
CY2022Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
8094000
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2671000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1666000
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
223000
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
243000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2437000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
620000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
272000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
494000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3916000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3878000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35846000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37413000
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
150638000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1587000
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
149051000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
185555000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1861000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
183694000
CY2023Q3 usph Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
7555000
CY2023Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7555000
CY2022Q4 usph Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
8271000
CY2022Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
408000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7863000
CY2023Q3 usph Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
143083000
CY2023Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1587000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
141496000
CY2022Q4 usph Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
177284000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1453000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
175831000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
12222000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
12821000
us-gaap Profit Loss
ProfitLoss
38513000
us-gaap Profit Loss
ProfitLoss
40059000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-1276000
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-6473000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-2340000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-5942000
CY2023Q3 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
326000
CY2022Q3 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
1654000
usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
598000
usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
1518000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13172000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
17640000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
40255000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
44483000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
9725000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
8870000
us-gaap Operating Lease Cost
OperatingLeaseCost
28500000
us-gaap Operating Lease Cost
OperatingLeaseCost
25974000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
292000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
210000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
851000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
790000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
2281000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1913000
us-gaap Variable Lease Cost
VariableLeaseCost
6785000
us-gaap Variable Lease Cost
VariableLeaseCost
5839000
CY2023Q3 us-gaap Lease Cost
LeaseCost
12298000
CY2022Q3 us-gaap Lease Cost
LeaseCost
10993000
us-gaap Lease Cost
LeaseCost
36136000
us-gaap Lease Cost
LeaseCost
32603000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
10007000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
9139000
us-gaap Operating Lease Payments
OperatingLeasePayments
29418000
us-gaap Operating Lease Payments
OperatingLeasePayments
26697000
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10188000
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8011000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
26407000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29618000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9946000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
36216000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
28184000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20552000
CY2023Q3 usph Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
24877000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
119775000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8445000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
111330000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.027
CY2023Q3 us-gaap Assets
Assets
1010186000
CY2022Q3 us-gaap Assets
Assets
799708000
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
usph-20230930_cal.xml Edgar Link unprocessable
usph-20230930_def.xml Edgar Link unprocessable
0001140361-23-052081-index-headers.html Edgar Link pending
0001140361-23-052081-index.html Edgar Link pending
0001140361-23-052081.txt Edgar Link pending
0001140361-23-052081-xbrl.zip Edgar Link pending
ef20012482_10q.htm Edgar Link pending
ef20012482_ex31-1.htm Edgar Link pending
ef20012482_ex31-2.htm Edgar Link pending
ef20012482_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ef20012482_10q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20230930.xsd Edgar Link pending
usph-20230930_lab.xml Edgar Link unprocessable
usph-20230930_pre.xml Edgar Link unprocessable